Amneal Gets US Nod For Lidoderm Rival

Lidocaine Patch Is Latest Complex Generic For US Firm

Amneal is adding to its portfolio of complex products with FDA approval for a generic version of Lidoderm.

Chalkboard_Labrynth
Amneal is banking on complex products to set it apart from the pack • Source: Shutterstock

Amneal Pharmaceuticals is continuing to deliver on its promise to pursue complex generics after receiving final US Food and Drug Administration approval for its version of Teikoku Pharma’s Lidoderm (lidocaine) 5% patch.

The approval for the post-herpetic neuralgia treatment represents the eighth nod among the 15 complex products that Amneal plans to...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin